In the present study, we conducted a hospital-based case-controlled investigation to evaluate the potential impact of the XRCC1 Arg399Gln gene polymorphism on the risk of CRC in a Kashmiri population. This evidence concerns the gene XRCC1 and colorectal carcinoma.